Author Correction: Identification of optimal dosing schedules of dacomitinib and osimertinib for a phase I/II trial in advanced EGFR-mutant non-small cell lung cancer

Kamrine E. Poels, Adam J. Schoenfeld, Alex Makhnin, Yosef Tobi, Yuli Wang, Heidie Frisco-Cabanos, Shaon Chakrabarti, Manli Shi, Chelsi Napoli, Thomas O. McDonald, Weiwei Tan, Aaron Hata, Scott L. Weinrich, Helena A. Yu () and Franziska Michor ()
Additional contact information
Kamrine E. Poels: Harvard T.H. Chan School of Public Health
Adam J. Schoenfeld: Weill Cornell Medical College
Alex Makhnin: Weill Cornell Medical College
Yosef Tobi: Weill Cornell Medical College
Yuli Wang: Pfizer Inc
Heidie Frisco-Cabanos: Massachusetts General Hospital Cancer Center
Shaon Chakrabarti: Harvard T.H. Chan School of Public Health
Manli Shi: Pfizer Inc
Chelsi Napoli: Massachusetts General Hospital Cancer Center
Thomas O. McDonald: Harvard T.H. Chan School of Public Health
Weiwei Tan: Pfizer Inc
Aaron Hata: Massachusetts General Hospital Cancer Center
Scott L. Weinrich: Pfizer Inc
Helena A. Yu: Weill Cornell Medical College
Franziska Michor: Harvard T.H. Chan School of Public Health

Nature Communications, 2022, vol. 13, issue 1, 1-1

Date: 2022
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/s41467-022-33355-0 Abstract (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:natcom:v:13:y:2022:i:1:d:10.1038_s41467-022-33355-0

Ordering information: This journal article can be ordered from
https://www.nature.com/ncomms/

DOI: 10.1038/s41467-022-33355-0

Access Statistics for this article

Nature Communications is currently edited by Nathalie Le Bot, Enda Bergin and Fiona Gillespie

More articles in Nature Communications from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().